Driving innovation that truly revolutionizes sectors is a team effort. That’s exactly what Acto Co-Founder and CTO Kumar Erramilli is looking to do in the realm of biopharma, and he’s working with the team here at Boast to maximize his innovation potential and build one of the fastest-growing startups in all of Canada in the process.

ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact.

With ACTO, biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness.

While all of this is impressive on its own, Kumar has a wealth of experience across the North American tech ecosystem, having played a role in numerous startups and tech-centric organizations in his career to date. He’s a passionate inventor of AI and software technologies that are looking to change the way Life Sciences industry consumes technology, and I can’t wait to pick his brain on what’s in store for Acto and his take on the state of startups in 2024.

Boast AI accelerates the success of innovative businesses globally with software that integrates financial, payroll, and engineering data into a single platform of R&D intelligence.

Visit Boast.ai, sign up for our Blog newsletter and follow us on LinkedIn for weekly #InnovatorsLive sessions and the latest news to fuel your growth.

Intro and Outro music provided by Dennis Ma whose mixes you can find on Soundcloud at DJ DennyDex.